RESUMO
Boron nitride nanotubes (BNNTs) have experienced considerable growth in recent years due to their unique intrinsic properties, in particular for the fabrication of polymer nanocomposites. Dispersion of pure BNNTs in nanocomposites is often difficult due to their poor compatibility with most polymer matrices. An approach involving the creation of hydroxyl groups on their surface could improve their dispersion. While some harsh oxidation processes have been reported so far, a mild oxidation of BNNTs using air as the oxidant is reported here. This new catalytic reaction leads to slightly oxidized BNNTs, which were characterized by scanning electron microscope, x-ray photoelectron spectroscopy, Fourier transform infrared spectroscopy and thermogravimetric analysis. Polycarbonate nanocomposites were then fabricated using pristine and oxidized BNNTs as nanofillers. The measured thermal conductivity increased linearly with the mildly oxidized BNNTs content. It reached a five-fold increase up to 1.19 W m.K-1at 15% vol. content which is significantly improved over nanocomposites fabricated with severely oxidized BNNTs, while the electrically insulating character remained unchanged.
RESUMO
STUDY OBJECTIVE: Hemoglobin measurement is a routine procedure, and a noninvasive point-of-care device may increase the quality of care. The aim of the present study is to compare hemoglobin concentration values obtained with a portable totally noninvasive device, the Masimo Labs Radical-7 Pulse CO-Oximeter, with the results obtained by the ADVIA 2120 in the laboratory. METHODS: This was a prospective monocentric open trial enrolling patients consulting in the emergency department of a university hospital from June 16 to December 17, 2009. The main outcome measure was the agreement between both methods and evaluation of the percentage of potential decision error for transfusion. RESULTS: Samples from 300 consecutive patients were assessed. Hemoglobin concentration could not be obtained with the new device for 24 patients. In others, the mean bias, the lower and the upper limits of agreement between the 2 methods, was 1.8 g/dL (95% estimated confidence interval [CI] 1.5 to 2.1 g/dL), -3.3 g/dL (95% CI -3.8 to -2.8 g/dL), and 6.9 g/dL (95% CI 6.4 to 7.4 g/dL), respectively. The intraclass correlation coefficient was 0.53 (estimated 95% CI 0.10 to 0.74). The number of potential errors about transfusion decision was 38 (13% of patients). The peripheral oxygen saturation and the true value of hemoglobin concentration were independently associated with the bias. CONCLUSION: Results from this widely available noninvasive point-of-care hemoglobin monitoring device were systematically biased and too unreliable to guide transfusion decisions.